Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Share News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Shares Cancelled Or Suspended In London Over Delayed Results

Thu, 02nd Jan 2020 09:36

(Alliance News) - Shares in Amphion Innovations PLC were cancelled from trading in London on Thursday due to delayed publication of its 2018 results, while another five companies' shares were suspended for the same reason.

Amphion's shares have been cancelled from trading on AIM as it has still not published its 2018 annual results. Amphion was a medical, life science, and technology business developer but became a cash shell in November 2019 when it sold its stake in Polarean Imaging PLC for USD2.6 million. Trading in its shares was suspended in June 2019.

Real estate investment trust KCR Residential REIT PLC, mobile content distributor Mobile Streams PLC, oil & gas explorer Pantheon Resources PLC, and gaming technology platform Nektan PLC all have had trading in their AIM shares suspended on Thursday pending publication of their audited annual results.

In addition, Carclo PLC has requested the suspension of its share listing on the London Main Market - having failed to publish its interim results. This follows delays to the publication of its annual results for its financial year ended March 2019 and work needed to exit its loss-making Wipac Ltd business.

Plastic parts manufacturer Carclo said it is at an advanced stage in the preparation of its interim results and these will be published "as soon as possible".

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Sep 2015 09:23

WINNERS & LOSERS SUMMARY: Dixons And Next Up But Morrisons Sinks

Read more
10 Sep 2015 07:12

Amphion Innovations' DataTern Gets Favourable Patent Dispute Ruling

Read more
3 Sep 2015 09:42

WINNERS & LOSERS SUMMARY: M&A Speculation And Upgrade Boost Morrisons

Read more
3 Sep 2015 07:46

Amphion Innovations Sees "Dramatic Rise" In Value On Motif Bio Float

Read more
23 Jun 2015 09:28

Amphion Innovations Confident After Motif IPO, 2014 Asset Value Fall

Read more
5 Jun 2015 10:59

LONDON MIDDAY BRIEFING: Vodafone In Asset Swap Talks With Liberty

Read more
5 Jun 2015 10:27

WINNERS & LOSERS: Halfords Rides Higher As Sales Hit GBP1 Billion

Read more
5 Jun 2015 07:11

Amphion Innovations Raises GBP1.5 Million In Discounted Issue (ALLISS)

Read more
15 Apr 2015 07:31

LONDON MORNING BRIEFING: Next And Burberry Shares In Fashion

Read more
15 Apr 2015 07:10

Amphion Shares Up As Motif Bio Gets US FDA Approval For Iclaprim Trial

Read more
7 Apr 2015 08:01

Amphion Innovations Gets GBP580,842 From Exercised Warrants (ALLISS)

Read more
2 Apr 2015 11:46

Motif Bio makes AIM debut, seeks approval for Iclaprim treatment

Clinical stage biopharmaceutical group Motif Bio began trading on AIM on Thursday, after raising £2.8m in its initial public offering. The group, whose 44.09% of issued equity is owned by Amphion, placed shares at 20p each, said it had 64,238,442 ordinary shares in issue and a market capitalisation

Read more
2 Apr 2015 08:19

BCA Marketplace, Marshall Motor And Motif Bio Begin Trading (ALLIPO)

Read more
24 Mar 2015 15:41

Amphion Issues 1.3 Million Shares At GBP0.0266 To YA Global Master (ALLISS)

Read more
20 Mar 2015 12:20

LONDON MIDDAY BRIEFING: TSB Banking To Go The Way Of Abbey National

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.